Paul B. Laub

Microscopic Benign and Invasive Malignant Neoplasms and a Cancer-Prone Phenotype in Prophylactic Oophorectomies

H Salazar, Andrew K. Godwin, Mary B. Daly et al. · JNCI Journal of the National Cancer Institute · 1996 · 275 citations · Full text

Medicine, Gynecology, Oncology +17

Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines.

Steven W. Johnson, Paul B. Laub, J.S. Beesley et al. · PubMed · 1997 · 178 citations

Medicine, Oncology, Toxicology +16

Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells

David W. Roberts, Jonathan Schick, Susan R. Conway et al. · British Journal of Cancer · 2005 · 140 citations · Full text

Medicine, Oncology, Pharmacology +17

A noncovalent peptide complex as a model for an early folding intermediate of cytochrome c

Lawren C. Wu, Paul B. Laub, Gülnur A. Elöve et al. · Biochemistry · 1993 · 94 citations

Life Sciences, Biochemistry, Biophysics +13

Population Pharmacokinetic Model for Topotecan Derived From Phase I Clinical Trials

James M. Gallo, Paul B. Laub, Eric K. Rowinsky et al. · Journal of Clinical Oncology · 2000 · 68 citations

Pharmacy, Pharmacokinetics, Pharmacology +15